Literature DB >> 27891340

Dual Lower Respiratory Tract Infection by Burkholderia cepacia and Acinetobacter baumannii in A Neonate: A Case Report.

Neeta Gade1, Sanjay Singh Negi2, Atul Jindal3, Ujjwala Gaikwad2, Padma Das4, Anudita Bhargava5.   

Abstract

Burkholderia cepacia (B.cepacia) and Acinetobacter baumannii (A.baumannii), the highly intrinsically resistant nonfermenters are known to cause frequent infections in immunocomproimsed or hospitalized patients with significant mortality rate. In this rare clinical presentation, both were simultaneously isolated from a case of neonatal sepsis with respiratory failure. The prompt early diagnosis and antibiogram of these nonfermenters were proved to be of tremendous help in the present case with successful treatment outcome of dual infection of B.cepacia and A.baumannii. The present case report strongly emphasises the clinical importance of early accurate diagnosis of these emerging potential fatal non-fermenters which could otherwise prove fatal in case of any slight delay or misidentification. Implementation of strict surveillance policy to monitor the growth of these non-fermenters and draconian infection control measure holds a key to success in significant reduction of the associated mortality and morbidity.

Entities:  

Keywords:  Drug resistance; Endotracheal (ET) tip and secretion; Non-fermenter

Year:  2016        PMID: 27891340      PMCID: PMC5121678          DOI: 10.7860/JCDR/2016/21983.8735

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  11 in total

1.  Burkholderia cepacia complex in septicaemic non-cystic fibrosis cases from two tertiary care hospitals in north India.

Authors:  Vikas Gautam; Anita Arora; S K Madhup; Anindita Das; P Vandamme; Kusum Sharma; Vipin Koushal; Deepak Bansal; Meera Sharma; R K Garg; Sudesh Rana; R K Marwaha; Pallab Ray
Journal:  Indian J Med Res       Date:  2010-06       Impact factor: 2.375

2.  Drug-resistant genes carried by Acinetobacter baumanii isolated from patients with lower respiratory tract infection.

Authors:  Ning Dai; De-zhi Li; Ji-chao Chen; Yu-sheng Chen; Rong Geng; Ying-hui Hu; Jing-ping Yang; Juan DU; Cheng-ping Hu; Wei Zhang; Jia-shu Li; Qin Yu; Huan-ying Wan; Lan Mu; Xiao-ning Zhong; Li-ping Wei; Jian-jun Ma; Qiu-yue Wang; Ke Hu; Gui-zhen Tian; Shao-xi Cai; Rui-qin Wang; Bei He; Si-qin Wang; Zhan-wei Wang; Su-rui Zhao; Zhan-cheng Gao
Journal:  Chin Med J (Engl)       Date:  2010-09       Impact factor: 2.628

3.  Etiological factors causing lower respiratory tract infections isolated from hospitalized patients.

Authors:  A Guzek; Z Rybicki; K Korzeniewski; K Mackiewicz; E Saks; A Chciałowski; E Zwolińska
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 4.  Therapeutic options for Burkholderia cepacia infections beyond co-trimoxazole: a systematic review of the clinical evidence.

Authors:  Sophia G Avgeri; Dimitrios K Matthaiou; George Dimopoulos; Alexandros P Grammatikos; Matthew E Falagas
Journal:  Int J Antimicrob Agents       Date:  2008-12-18       Impact factor: 5.283

5.  Cervical osteomyelitis caused by Burkholderia cepacia after rhinoplasty.

Authors:  Lenny Weinstein; Christin A Knowlton; Miriam A Smith
Journal:  J Infect Dev Ctries       Date:  2008-02-01       Impact factor: 0.968

6.  A rare case of community acquired Burkholderia cepacia infection presenting as pyopneumothorax in an immunocompetent individual.

Authors:  Suman S Karanth; Hariharan Regunath; Kiran Chawla; Mukhyaprana Prabhu
Journal:  Asian Pac J Trop Biomed       Date:  2012-02

7.  Two novel clinical presentations of Burkholderia cepacia infection.

Authors:  Chiranjoy Mukhopadhyay; Anudita Bhargava; Archana Ayyagari
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

8.  Burkholderia cepacia Complex: Emerging Multihost Pathogens Equipped with a Wide Range of Virulence Factors and Determinants.

Authors:  Sílvia A Sousa; Christian G Ramos; Jorge H Leitão
Journal:  Int J Microbiol       Date:  2010-08-03

9.  Molecular characterisation and control of Acinetobacter baumannii isolates resistant to multi-drugs emerging in inter-intensive care units.

Authors:  Ayşe Ertürk; Ayşegül Çopur Çiçek; Aziz Gümüş; Erkan Cüre; Ahmet Şen; Aysel Kurt; Alper Karagöz; Nebahat Aydoğan; Cemal Sandallı; Rıza Durmaz
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-07-22       Impact factor: 3.944

10.  Multidrug resistant Gram-negative bacilli in lower respiratory tract infections.

Authors:  Shashidhar Vishwanath; Kiran Chawla; Anusha Gopinathan
Journal:  Iran J Microbiol       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.